Emcure Pharmaceuticals, backed by Namita Thapar, made a remarkable debut on the Indian stock exchanges on Wednesday, July 10. The shares were listed at ₹1,325.05 apiece on the BSE, reflecting a 31.45 percent premium over the issue price of ₹1,008. Following the listing, Emcure Pharma’s shares climbed further to ₹1,384, […]